Ra. Malinauskas et al., ASSOCIATION BETWEEN SECONDARY FLOW IN MODELS OF THE AORTO-CELIAC JUNCTION AND SUBENDOTHELIAL MACROPHAGES IN THE NORMAL RABBIT, Atherosclerosis (Amsterdam), 140(1), 1998, pp. 121-134
In order to examine the association between arterial fluid dynamics an
d the distribution of subendothelial macrophages in the normal rabbit
aorta, steady and pulsatile particle flow visualization was performed
in a geometrically realistic model of the rabbit aorto-celiac junction
region. Over a range of aorto-celiac steady flow ratios, particle pat
hlines along the upstream lateral aortic walls curved to enter the cel
iac orifice, while two asymmetric regions of reversing spiral secondar
y flow originated along the downstream lateral portions of the orifice
flow divider. These regions increased in size as either the Reynolds
number or flow into the celiac artery increased. In pulsatile flow stu
dies, particles along the lateral aortic walls near the celiac orifice
began to spiral into the branch during peak systole. During systolic
deceleration, the size of this spiral flow region increased as particl
es reversed direction to enter the celiac orifice. This contrasted wit
h flow patterns directly upstream and downstream of the orifice, which
remained unidirectional throughout this period even along the distal
lip of the orifice. The highest frequency of subendothelial white bloo
d cells in the normal rabbit aorta was associated with regions where s
econdary flow patterns occurred, and where the orientation of endothel
ial cell nuclei deviated from the major direction of aortic flow. Seco
ndary flow patterns may aid the accumulation of monocytes and macropha
ges about the lateral regions of the celiac artery flow divider by tra
nsporting monocytes to the walls, allowing them time to attach to the
endothelial cells, or by stimulating the endothelial cells to express
leukocyte adhesion molecules. These same regions are associated with i
ncreased endothelial permeability to low density lipoprotein and, unde
r hypercholesterolemic conditions, lesion origination. (C) 1998 Elsevi
er Science Ireland Ltd. All rights reserved.